Is the GM stock rally just beginning?
Bank of America's John Murphy stops by to discuss why it's good to be GM right now and for the foreseeable future. GM has secured the Yahoo Finance Surprise of the Year award.
Bank of America's John Murphy stops by to discuss why it's good to be GM right now and for the foreseeable future. GM has secured the Yahoo Finance Surprise of the Year award.
EVgo Inc. (NASDAQ:EVGO) shares are trading lower in premarket trading following the announcement of the pricing of a secondary public offering. The previously announced offering by EVgo Holdings, an affiliate of LS Power Equity Partners IV, involves 23 million shares of EVgo’s Class A common stock priced at $5.00 per share. Additionally, LS Power has granted underwriters a 30-day option to purchase up to 3.45 million more shares at the same price. Notably, EVgo itself is not selling any shares,
Frustration with healthcare, including pharmacy benefit managers (PBMs), continues to make news in the weeks following Brian Thompson’s death.
Rockwell Medical, Inc. (NASDAQ:RMTI) shares are trading higher premarket on Tuesday after it entered into a product purchase agreement with a provider of dialysis products and services. As per the three-year agreement, Rockwell Medical will supply its SteriLyte liquid bicarbonate product to the customer, with an option to renew it for two additional one-year terms. The agreement is expected to generate over $10 million in net sales in the first year, a portion of which was not included in Rockwe
(Bloomberg) -- Wall Street’s printing press for complex investment products is having a blockbuster year, minting fees for bankers, hedge fund managers and ETF issuers. Most Read from BloombergHow California Sees the World, and ItselfHong Kong's Expat Party Hub Reshaped by Chinese InfluxLondon’s Tube Fares Are Set to Rise by 4.6% Next YearYet a slew of these newfangled strategies are struggling to wow — despite healthy demand — in a world where plain and simple bets on the S&P 500 keep winning b
EyePoint (EYPT) announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 54,600 shares of EyePoint Pharmaceuticals common stock to six new employees. The stock options were granted on December 13, 2024. The grants were approved by the Compensation Committee and made as an inducement m
The benchmark US stocks were pointing mostly lower pre-bell on Tuesday, with the Dow Jones Industria
The company forecast revenue next year will grow slightly versus this year, when excluding certain factors. “The uncertainty caused by COVID [is] mostly resolved,” its CFO said.
AI has been driving the markets for the past two years, proving that the technology truly is a game changer – and for multiple games. AI has impacted cloud computing, networking services, content and graphic design – the list seems limitless. While this is undoubtedly good for the economy, and it’s helped boost the stock market to record levels, it’s also driving gains for individual companies and their investors, even beyond the expected horizon of AI stocks. Looking at the tech sector and its